WPC l-_:c 9Z4bvJRKNfՖ|mG>ʑh=$f ¡W,0+jH29 k>y5s3>B P\GT;-I58!8 0 e >rTc Z"5_D ,3q+UŞW:LkJɩh8&vx }X\eg/8 @.#zQmXf&L<4Zٟf RxC"˪%6}S.UX@ҠWl ,xI0pb5D _1Ak #RmR;%ֱ?y|]%KևL+of4b%d`Gns}ً̂dM9絴`IYRmӈeL<OW j9g#UN_ % 0:UN^ ;wG4K_n mp 1u 72 0Zc.hp LaserJet 1300 PCL 5e,,,,0(9 Z6Times New Roman RegularX($USUS.,(9 Z 6Times New Roman RegularwH2 a1:i+003|xU3#37=CIQYag1.a.i.(1)(a)(i)1)a) i)(;3$2#  0  .3  0  !USUS.,  _ XXXX  XXUnit14Objectives:HLA #@#Ԁ andTransplantationMedicine#XXk#   __XXXX_"3"  3t2#  1  .3  0    ListthetypesoftissuesandcellswhichpossessHLAantigens.3t݌(#(# Ќ  "3"  3|2#  2  .3  0    DescribetheimportanceofHLAantigens.3|݌(#(# Ќ  "3"  3m2#  3  .3  0    Statethefunctionofthemajorhistocompatibilitycomplex(MHC).3m݌(#(# Ќ  "3"  3w2#  4  .3  0    ExplainhowtheHLAsystemwasdiscovered.3w݌x (#(# Ќ  "3"  3j2#  5  .3  0    ListtheHLAantigensincludedintheclassI,IIandIIIcategories.0 (#(#3j݌d  (# (# Ќ  "3"  32#  6  .3  0    DescribehowclassIandclassIIantigensfunctionastargetsforTlymphocytes.3݌P (#(# Ќ  "3"  32#  7  .3  0    DescribetheassociationbetweenHLAandcertaindiseases.3݌< (#(# Ќ  "3"  32#  8  .3  0    BrieflydescribetheprincipleofthelympocytoxicitytestforHLAantigens.0 (#(#0@ (#(#0@!p(#p(#0@!(#(#3݌( x  (# (# Ќ  "3"  3 2#  9  .3  0    Brieflydescribetheprincipleofthemixedleukocyteculture(MLC)test.3 ? ݌d (#(# Ќ  "3 "  3$ 2#  10  .3  0    Brieflydescribedonorrecipienttesting.3$ Q ݌P (#(# Ќ  "3 "  3 2#  11  .3  0    Brieflydescribetheprincipleoftheprimedlymphocytetest(PLT).3 D ݌< (#(# Ќ  "3 "  3$ 2#  12  .3  0    DescribetheimportanceofHLAcompatibilityasitrelatestograftvshostdisease.3$ Q ݌( (#(# Ќ  "3 "  3B2#  13  .3  0    ListtheHLAantigensroutinelytestedforpriortotransplantation.3Bo݌ (#(# Ќ  "3 "  3P2#  14  .3  0    Describetheprincipleinvolvedinthetransfusionofpotentialkidneytransplant0 (#(#0@f!(#(#0@f!p(#p(#0@f!(#(#3P}݌ (# (# Ќ  0  patients.(#(# "3"  32#  15  .3  0    DescribetheimportanceofABOantigensasitrelatestoorgantransplantation.3݌(#(# Ќ  "3"  3 2#  16  .3  0    Describethe2bloodbankprotocolsutilizedinprovidingbloodandbloodcomponents t forlivertransplantpatients.3 8݌`(#(# Ќ  "3"  3\2#  17  .3  0    Explainwhylivertransplantprogramsrequiresmaximalsupport,cooperationand L commitmentfromallorganizations/departmentsinvolved.3\݌8(#(# Ќ  "3"  32#  18  .3  0    Describethedonorcriteriaandbloodbanksupportforhearttransplants.3݌$t(#(# Ќ  "3"  32#  19  .3  0    Describethetransfusionrequirementsforpancreastransplants.3݌`(#(# Ќ  "3"  32#  20  .3  0    Describethetypesofpatientswhoarecandidatesforautologousbonemarrow L transplants.3 ݌8(#(# Ќ  "3"  32#  21  .3  0    Brieflydescribetheprocedureutilizedautologousbonemarrowtransplants.3A݌$(#(# Ќ  "3"  3)2#  22  .3  0    Statethetransfusionprotocolsforpatientsundergoinghomologousbonetransplantsand0@"(#(#0@"p(#p(#0@"(#(#0@" (# (#3)V݌(#(# Ќ  0  theirimportance.0(#(#0h(#(#0h(#h(#0(#(# p   (#(# "3"  3B2#  23  .3  0    ExplainwhytheHLAtypeisofgreaterimportancethanABOinbonemarrowtransplants  (BMT).3Bo݌ (#(# Ќ  "3"  3|2#  24  .3  0    Describetheprocessinvolved,eventualbloodtypeofrecipientandtransfusionof_BMTs_ p! involvingamajorABOincompatibility.3|݌\" (#(# Ќ  "3"  32#  25  .3  0    DescribetheprocedureutilizedwhentheBMThasaminorsideABOincompatibility.3%݌H#!(#(# Ќ  "3"  32#  26  .3  0    DescribechimerismandhowthismayoccurafterBMT.3A݌4$"(#(# Ќ  "3"  3 2#  27  .3  0    DescribepurposeofandthetestingperformedonpotentialdonorsfortheNationalBone  %p # MarrowDonorRegistry.3 ? ݌ &\!$(#(# Ќ  "3"  3^!2#  28  .3  0    Define hematopoieticstemcellsand progenitorcells.0(#(#3^!!݌&H"%(#(# Ќ  "3"  3"2#  29  .3  0    Listanddescribethethreetypesoftransplantoptionsavailableforhematopoieticstem '4#& cells.3""݌( $'(#(# Ќ  "3"  3#2#  30  .3  0    Statetheadvantageofusingumbilicalcordbloodasanalternativetobonemarrow ) %( transplants.#XXXXE#